Rhythm and conduction disorders in children with hypertrophic cardiomyopathy
- 5 October 2026
- journal article
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 71 (4) , 59-67
Abstract
Rhythm and conduction disorders remain key determinants of prognosis in hypertrophic cardiomyopathy. Objective. To assess the nature, frequency, and clinical-prognostic significance of cardiac rhythm and conduction disorders in children with hypertrophic cardiomyopathy. Materials and Methods . This retrospective-prospective study included 200 children with confirmed primary hypertrophic cardiomyopathy (median age 14.34 years; 2/3 male). Median follow-up was 5.74 years. Life-threatening arrhythmias were defined as sudden cardiac death, aborted sudden cardiac death, or appropriate implantable cardioverter-defibrillator therapy. Results. Rhythm and conduction disorders were detected in 77 % of children. Ventricular extrasystole ≥ 10/24h was observed in 25.5 %, and non-sustained ventricular tachycardia in 20.5 %. Life-threatening arrhythmias occurred in 27 children (13.5 %): sudden cardiac death (n = 6), aborted sudden cardiac death (n = 11), and appropriate implantable cardioverter-defibrillator shocks for primary prevention (n = 10). Ventricular extrasystole 10–500/24h (OR 4.93; p = 0.00002) and ventricular extrasystole ≥ 500/24h (OR 6.84; p = 0.015) were associated with non-sustained ventricular tachycardia. Extreme myocardial hypertrophy increased the odds of non-sustained ventricular tachycardia 2.3-fold (p = 0.018). Sick sinus syndrome was diagnosed in 10.5 % of children and was a strong predictor of life-threatening arrhythmias (OR 5.18; pConclusion . Hypertrophic cardiomyopathy is characterized by a high prevalence of rhythm and conduction disorders. Even moderate ventricular extrasystole is associated with non-sustained ventricular tachycardia, justifying routine Holter monitoring in all children with hypertrophic cardiomyopathy. Sick sinus syndrome is associated with a fivefold increased risk of life-threatening arrhythmias and should be incorporated into sudden cardiac death risk stratification algorithms. Such patients may warrant a lower 5-year sudden cardiac death risk threshold for dual-chamber cardioverter-defibrillator implantation.Keywords
This publication has 35 references indexed in Scilit:
- Prognostic role of novel variables in sudden cardiac death risk associated to hypertrophic cardiomyopathyAnales de Pediatría (English Edition), 2025
- Implications of primary bradycardia in patients with hypertrophic cardiomyopathyHeart Rhythm, 2024
- Burden Of Arrhythmias In Patients With Hypertrophic Cardiomyopathy, Nation-Wide StudyJournal of Cardiac Failure, 2024
- Patterns of Electrocardiographic Abnormalities in Children with Hypertrophic CardiomyopathyPediatric Cardiology, 2023
- Epidemiology of Pediatric Hypertrophic Cardiomyopathy in a 10-Year Medicaid CohortPediatric Cardiology, 2020
- Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathyInternational Journal of Cardiology, 2018
- Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic CardiomyopathyJACC, 2013
- Microvascular Dysfunction, Myocardial Ischemia, and Progression to Heart Failure in Patients with Hypertrophic CardiomyopathyJournal of Cardiovascular Translational Research, 2009
- Mutation of theMYH7 gene in a child with hypertrophic cardiomyopathy and Wolff-Parkinson-White syndromeJournal of Applied Genetics, 2007
- Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathyJACC, 1988